Answers are grounded in this paper and cite their sources.
Stimuli-responsive self-assembling peptides have emerged as promising biomaterials for disease treatment, while strategies that promote peptide assembly through specific biological targets remain underexplored. Here, we designed a receptor-responsive bispecific self-assembling peptide (PAK(N)A) by integrating VEGFR2 and Tie2 binding motifs with a β-sheet forming sequence. Binding to VEGFR2 and Tie2 promoted the self-assembly of PAK(N)A into nanofibrous networks, enabling simultaneous blockage of both VEGFR2 and Tie2 signaling pathways. PAK(N)A effectively suppressed endothelial cell proliferation, migration, and tube formation while exhibiting good biocompatibility. Following topical administration, PAK(N)A efficiently penetrated ocular tissues and significantly reduced pathological angiogenesis in both oxygen-induced retinopathy (OIR) and laser-induced choroidal neovascularization (CNV) mouse models at a dose of 2 mM. Intravenous administration of PAK(N)A (5 mg kg-1) also markedly inhibited hepatocellular carcinoma angiogenesis and tumor growth without detectable systemic toxicity. This work presents a receptor-responsive bispecific self-assembling peptide in which target recognition promotes self-assembly, providing a versatile biomaterial strategy for dual-receptor inhibition and anti-angiogenic therapy.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: